CURE International

CURE International Children's Hospitals
Founded1996
FounderC. Scott Harrison, Sally Harrison
TypeInternational child healthcare organization
FocusInternational Healthcare
HeadquartersGrand Rapids, Michigan, US
Location
  • Niger, Malawi, Zambia, Zimbabwe, Ethiopia, Uganda, Kenya, the Philippines
Area served
Africa and Asia
MethodSurgery, advocacy, treatment
Key people
Justin Narducci, President/CEO
Revenue
$35 million
Employees
1200
Websitecure.org

CURE International, based in Grand Rapids, MI, is a Christian nonprofit organization that owns and operates eight charitable children's hospitals around the world.[1] CURE provides medical care to pediatric patients with orthopedic, reconstructive plastic, and neurological conditions. The organization's stated mission is to "heal the sick and proclaim the kingdom of God."[2] The organization currently operates hospitals in Ethiopia, Kenya, Malawi, Niger, the Philippines, Uganda, Zambia and Zimbabwe.[3]

CURE treats conditions like clubfoot, knock knees, bowed legs, cleft lip/palate, burn contractures, hydrocephalus, and encephalocele.[4]

  1. ^ "The Mission of CURE". CURE. 2013. Retrieved 25 April 2014. As a Christian organization, we can help them through this difficult time. For the last 2,000 years, what they are looking for has been called the "kingdom of God." It is something to obtain in the future, but it also something here now. It is a reference to Jesus but is also within those who follow Him. Helping people find that kingdom of God is the other half of what we do. So the answer to my question is simple: CURE International, healing the sick and proclaiming the kingdom of God. That's our mission!
  2. ^ Zimbabwe, Ryan Truscott in (2022-01-14). "Faith Leads Doctor Back to Zimbabwe". News & Reporting. Retrieved 2023-07-11.
  3. ^ "CURE International Teams with Thoughtworks to Digitize Pediatric Surgical Hospitals". www.businesswire.com. 2023-06-13. Retrieved 2023-07-11.
  4. ^ Irwin, Shelley (2022-05-26). "Cure International". WGVU NEWS. Retrieved 2023-07-11.